Kiora Pharmaceuticals Inc

Kiora Pharmaceuticals Inc(KPRX)の株価予測

$2.620

-0.039 (-1.50%)終値時点

価格予想

1-Day Price Prediction
+1.80%
1-Week Prediction
+2.26%
1-Month Prediction
2026 Prediction
2030 Prediction

アプリで開くと、より長期の予想を確認できます。

Loading chart…

類似チャート分析による KPRX の予測・予想

Alphio's KPRX stock price prediction model matches the current Kiora Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $2.67 (+1.80%). The 1-week path is $2.68 (+2.26%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Kiora Pharmaceuticals Inc 株は買うべき?

Kiora Pharmaceuticals Inc is currently not a strong buy due to its recent financial losses and lack of profitability. The stock price is at $2.62, with a forward P/E ratio of 2.41, indicating potential undervaluation, but the company has reported a loss of $0.58 per share in Q1 2026. The RSI is at 49.46, suggesting the stock is neither overbought nor oversold, which means it may not be the best time to buy. The main risk is the negative earnings trend, with a projected EPS of -0.34 for the last quarter, indicating ongoing financial challenges.

KPRX の株価は Friday に $2.62 で引け、その前に下落 -1.50%

Kiora Pharmaceuticals Inc (KPRX) last closed at $2.62, losing -1.50%. These facts feed the 1-day and 1-week KPRX price prediction above.

予想の要因

Kiora Pharmaceuticals Inc(KPRX)の予想は、類似したチャートパターン・季節性・移動平均を組み合わせています。

Similar patterns

Positive

Bullish

Seasonality

Negative

Bearish

SMA 20

Positive

Bullish

SMA 200

Positive

Bullish

類似チャートパターン

直近の値動きが KPRX に最も近い銘柄を、類似度順に表示します。

KPRX の季節性分析

Historically the probability of a positive August return for KPRX is 31.75%. February offers the highest probability of a positive month at 75.86%, while September is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.

Loading chart…

本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。

無料で始める